Get the Stockscreener App
0.3795
1.40%
-0.0054
Silo Pharma Inc stock is traded at $0.3795, with a volume of 115.71K.
It is down -1.40% in the last 24 hours and down -3.92% over the past month.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
See More
Previous Close:
$0.3849
Open:
$0.3799
24h Volume:
115.71K
Relative Volume:
0.12
Market Cap:
$5.05M
Revenue:
$72,100
Net Income/Loss:
$-3.60M
P/E Ratio:
-0.3189
EPS:
-1.19
Net Cash Flow:
$-3.37M
1W Performance:
-12.64%
1M Performance:
-3.92%
6M Performance:
-35.94%
1Y Performance:
-54.55%
1-Day Range:
$0.3712
$0.3944
1-Week Range:
$0.3712
$0.4373
52-Week Range:
$0.3601
$3.3699
Silo Pharma Inc Stock (SILO) Company Profile
Name
Silo Pharma Inc
Sector
Industry
Phone
(718) 400-9031
Address
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
2.95 | 4.38B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
5.50 | 322.13M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.77 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
5.07 | 185.60M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.8118 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Stock (SILO) Latest News
How Silo Pharma Inc. stock responds to policy changesPortfolio Performance Report & High Accuracy Swing Entry Alerts - ulpravda.ru
Gains Report: Is Silo Pharma Inc. stock a buy in volatile markets2025 Trading Recap & AI Forecasted Entry and Exit Points - ulpravda.ru
Momentum Shift: How geopolitical tensions affect Silo Pharma Inc. stockRecession Risk & Real-Time Chart Pattern Alerts - ulpravda.ru
Can Silo Pharma Inc. stock resist market sell offs2025 Earnings Surprises & Daily Entry Point Alerts - Улправда
Why Silo Pharma Inc. stock remains resilientBuy Signal & High Accuracy Trade Signal Alerts - ulpravda.ru
Is Silo Pharma Inc. stock a safe investment in uncertain markets2025 Market Sentiment & Stepwise Trade Signal Guides - ulpravda.ru
Can Silo Pharma Inc. stock sustain institutional interestEarnings Trend Report & Weekly Stock Performance Updates - ulpravda.ru
VIX Spike: Is Silo Pharma Inc. stock a safe haven assetQuarterly Market Summary & High Win Rate Trade Tips - moha.gov.vn
Silo Pharma (SILO) CEO Eric Weisblum reports December insider share purchases - Stock Titan
What drives Silo Pharma Inc stock priceGrowth vs. Value Investing & Download Our Free Trading Blueprint - earlytimes.in
Silo Pharma (NASDAQ:SILO) Stock Price Down 2.8% – What’s Next? - Defense World
How Silo Pharma Inc. stock performs during Fed tightening cycles2025 Top Decliners & Community Verified Trade Alerts - Newser
SILO Pharma (SILO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Silo Pharma Inc a good long term investmentContrarian Investment Ideas & Free Record-Breaking Gains - earlytimes.in
Silo Pharma CEO Weisblum buys $735 in company stock By Investing.com - Investing.com Australia
Silo Pharma CEO Weisblum buys $735 in company stock - Investing.com India
[Form 4] Silo Pharma, Inc. Insider Trading Activity - Stock Titan
Will earnings trigger a reversal in Silo Pharma Inc.Market Risk Report & Smart Investment Allocation Tips - newser.com
Is Silo Pharma Inc. stock attractive for long term wealth buildingEntry Point & Long-Term Safe Return Strategies - newser.com
Is now a turning point for Silo Pharma Inc.July 2025 Analyst Calls & Accurate Intraday Trade Tips - newser.com
Silo Pharma selects Allucent to support PTSD treatment IND submission By Investing.com - Investing.com Nigeria
Evaluating Silo Pharma Inc. with trendline analysisMarket Rally & Weekly Stock Performance Updates - newser.com
Silo Pharma selects Allucent to support PTSD treatment IND submission - Investing.com
Silo Pharma partners with Allucent to support planned FDA Investigational New Drug application for SPC-15 as a therapeutic for PTSD - MarketScreener
Silo Pharma Partners With Allucent To Support Planned FDA Investigational New Drug Application For Spc-15 As A Therapeutic For Ptsd - TradingView
Silo Pharma Partners with Allucent to Support Planned FDA - GlobeNewswire
Can Silo Pharma Inc. stock deliver strong Q4 earningsNew Guidance & Free Safe Entry Trade Signal Reports - newser.com
Will Silo Pharma Inc. rebound enough to break evenExit Point & Weekly Watchlist for Hot Stocks - newser.com
Combining price and volume data for Silo Pharma Inc.July 2025 Trends & Consistent Profit Trade Alerts - newser.com
[10-Q] Silo Pharma, Inc. Quarterly Earnings Report | SILO SEC FilingForm 10-Q - Stock Titan
Silo Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Silo Pharma Inc Stock (SILO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):